Investors

Growing Shareholder Value

Press Releases

Abiomed Fourth Quarter Fiscal 2018 Earnings and Conference Call Notification

Apr 13, 2018
Read More

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

Apr 04, 2018
Read More

Abiomed Receives FDA Approval for Impella CP® with SmartAssist™ and Optical Sensor

Apr 02, 2018
Read More

Abiomed to Appoint New Chief Financial Officer Todd A. Trapp

Mar 30, 2018
Read More

Abiomed Showcases Impella® Technology that Enables Heart Recovery at ACC with 25 Presentations

Mar 05, 2018
Read More

Abiomed Receives Approval for Expanded FDA Indication for High Risk Percutaneous Coronary Intervention (PCI) Procedures

Feb 14, 2018
Read More

Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women's Initiative for Heart Recovery

Feb 13, 2018
Read More

Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock

Feb 13, 2018
Read More

Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year

Feb 01, 2018
Read More

Abiomed Third Quarter Fiscal 2018 Earnings and Conference Call Notification

Jan 12, 2018
Read More
View all